{
    "clinical_study": {
        "@rank": "88870", 
        "arm_group": [
            {
                "arm_group_label": "Cevimeline", 
                "arm_group_type": "Active Comparator", 
                "description": "Cevimeline vs Pilocarpine"
            }, 
            {
                "arm_group_label": "Pilocarpine", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objectives were: 1) To determine the efficacy of both cevimeline and pilocarpine in\n      the secretion of saliva in patients with xerostomia, and 2) To compare the side-effects\n      between the treatment for xerostomia with cevimeline and with pilocarpine."
        }, 
        "brief_title": "Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva", 
        "completion_date": {
            "#text": "July 2010", 
            "@type": "Actual"
        }, 
        "condition": "Dry Mouth", 
        "condition_browse": {
            "mesh_term": "Xerostomia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Dry mouth"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 6, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01690052", 
            "org_study_id": "9999"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cevimeline", 
                "description": "Cevimlenine Vs Pilocarpine, cross over design, 4 weeks, one week wash out", 
                "intervention_name": "Cevimeline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Pilocarpine", 
                "description": "Cevimlenine Vs Pilocarpine, cross over design, 4 weeks, one week wash out", 
                "intervention_name": "Pilocarpine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pilocarpine", 
                "Cevimeline"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "dry mouth", 
        "lastchanged_date": "September 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Lexington", 
                    "country": "United States", 
                    "state": "Kentucky", 
                    "zip": "40536"
                }, 
                "name": "University of Kentucky Orofacial Pain Center College of Dentistry"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Cevimeline vs. Pilocarpine in the Secretion of Saliva", 
        "overall_official": {
            "affiliation": "University of Kentucky", 
            "last_name": "Juan F Yepes, DDS, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome measure is the increase of stimulated and non-stimulated saliva in ml from the baseline record. At each appointment, participants will provide 2 saliva samples to measure their current salivary output. The first measurement will be obtained by having the patient spit as much as he or she could into a cup for five minutes. The amount of saliva in ml will be recorded. The second measurement will be obtained in a similar manner with the addition of having the patient chew on a block of unflavored wax. Patients will complete weekly questionnaires to help determine which side-effects they experience as they take the medications.", 
            "measure": "Increase saliva production in ml.", 
            "safety_issue": "Yes", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01690052"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Kentucky", 
            "investigator_full_name": "Juan F. Yepes DDS, MD,", 
            "investigator_title": "Medical IRB Vice-Chair", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "We will record the number and type of side effects associated with each medication.", 
            "measure": "Number of participants with adverse effects associated with the medications", 
            "safety_issue": "Yes", 
            "time_frame": "4 weeks"
        }, 
        "source": "University of Kentucky", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Kentucky", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}